- €913.86m
- €545.57m
- €314.33m
Annual income statement for Philogen SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.5 | 23.7 | 23.1 | 74 | 314 |
| Cost of Revenue | |||||
| Gross Profit | -4.34 | 14 | 9.26 | 58.3 | 290 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 19.3 | 23.5 | 32 | 36.3 | 56.9 |
| Operating Profit | -16.8 | 0.24 | -8.84 | 37.7 | 257 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -15.2 | -4.36 | -6.18 | 40.4 | 260 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.7 | -5.38 | -6.16 | 45.3 | 230 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.7 | -5.38 | -6.16 | 45.3 | 230 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.7 | -5.38 | -6.16 | 45.3 | 230 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.377 | -0.132 | -0.153 | 1.12 | 5.7 |
| Dividends per Share |